It is a therapeutic vaccine, which means that it does not prevent the appearance of cancer, but rather helps in its treatment. The drug presents “favorable safety and effectiveness data,” both in the studies carried out inside and outside Cuba, as well as in its application at the differe...
CUBA: LUNG CANCER VACCINE MAY SOON HIT GLOBAL MARKETSPatricia Grogg
The vaccine works by limiting a patient’s ability to produce a hormone called EGF. This hormone has beenshown to play a pivotal role in cell divisionand the growth of malignant cells. As cancer is the result of cells dividing again and again to create tumours, the vaccine reduces this gro...
Cuba’s relative isolation seems to not have adversely affected the development of its health service. The country produces around 65 percent of its own medicines and even exports some sophisticated drugs, such as CIMAvax, a lung cancer vaccine that is currently undergoing clinical trials in Roswel...
High safety marks for Merck's Gardasil Cuba tests prostate cancer vaccine HIV's weak spot: V2 Unique anti-cancer agent ColoAd1 enters the clinic Broadly neutralizing antibodies against influenza A and B discovered Clinical trials initiated: Nexvax2 therapeutic vaccine for celiac disease The 20 top...
cancer. NGcGM3 ganglioside is a tumor-specific antigen expressed in human breast tumors. TheVSSP vaccine, consisting in very small-sized proteoliposomes (VSSP) obtained by the incorporation of NGcGM3 into the outer membrane protein complex of Neisseria meningitidis, has been tested in a Phase ...
but also the raw materials and science and technology needed to produce them. And as the most effective cancer treatments are often U.S.-produced and doctors do not have access to those, they often seek alternative treatments that are not as effective. This has an obvious impact on survival...
In keeping with its mission to prioritize public health and the National Health System, BioCubaFarma has consolidated a deep product pipeline that includes prophylactic and therapeutic vaccines, innovative biopharmaceutical products for cancer, cardiovascular disease (CVD), neurology, and other indications,...
主要目的:在cUTI或AP患者中与亚胺培南/西司他丁相比,评价静脉输注头孢吡肟/Nacubactam的有效性和安全性以及氨曲南/Nacubactam的安全性。 次要目的: 评价氨曲南/Nacubactam静脉输注给药治疗cUTI或AP的有效性; 评价头孢吡肟/Nacubactam和氨曲南/Nacubactam静脉输注给药治疗cUTI或AP继发性菌血症的有效性;...
More recently, the Synthetic Antigen Laboratory at the University of Havana in Havana, Cuba has played a leading role in developing the world's first human vaccine with a synthetic antigen. Ongoing work includes research on recombinant Dengue vaccine, preventative and therapeutic AIDS vaccines, ...